Nomegestrol acetate and vascular reactivity: Nonhuman primate experiments

Steroids

Volumn 65, Issue 10-11, 2000, Pages 621-627

  Paris, Jacques M ^a   Williams, Koudy J ^b   Hermsmeyer, Kent R ^c   Delansorne, Rémi ^a  

^a MERCK KGAA   (Germany)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Blood vessels; Nomegestrol acetate; Progestins; Steroids

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NOMEGESTROL ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ATHEROGENIC DIET; CELL PROLIFERATION; CELL SECRETION; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY SPASM; DRUG EFFICACY; ENDOMETRIUM; FEMALE; HORMONE SUBSTITUTION; MONKEY; NONHUMAN; OVARIECTOMY; TREATMENT OUTCOME;

ACETYLCHOLINE; ANIMALS; ARTERIES; BLOOD FLOW VELOCITY; CELL DIVISION; CORONARY DISEASE; CORONARY VASOSPASM; ENDOMETRIUM; ESTRADIOL; FEMALE; MACACA FASCICULARIS; MACACA MULATTA; MEDROXYPROGESTERONE 17-ACETATE; MEGESTROL; MODELS, ANIMAL; NORPREGNADIENES; PROGESTERONE CONGENERS; VASOCONSTRICTION;

ANIMALIA; MACACA FASCICULARIS; MACACA MULATTA; PRIMATES;

EID: 0033673155     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00118-5     Document Type: Conference Paper

References (92)

1. Incidence of coronary artery disease among women in an autopsy series (1780 cases)
2. Gender differences in mortality after acute myocardial infarction in the 1990s in Israel
3. Mortality differences between men and women following first myocardial infarction
4. Sex-based differences in early mortality after myocardial infarction
5. Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy
6. Estrogen: Key player in heart disease among women
7. Pregnancy-associated inhibition of coronary artery atherosclerosis in monkeys
8. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atheroscelerosis
9. Effects of estrogen on atherosclerosis formation and serum nitrite/nitrate concentrations in cholesterol-fed ovariectomized rabbits
10. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery
11. Long-term inhibition of nitric oxide synthesis significantly reduces the anti-atherogenic effect of estrogen in cholesterol-fed ovariectomized rabbits
12. Estrogen replacement therapy accelerates re-endothelialization of balloon injured arteries in ovariectomised rat model
13. 17β-estradiol inhibits restenosis after coronary angioplasty in pigs
14. Estrogen therapy facilitates the restoration of endothelial cell function in balloon-injured rats
15. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: Effects on migration and proliferation of vascular smooth muscle cells
16. 17β estradiol retards the progression of severe atherosclerosis induced by high cholesterol diet plus balloon injury: The relation of NO
17. Effect of low-dose estradiol on experimental atherosclerosis in male Yucatan minipigs
18. Menopause and coronary heart disease
19. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
20. Hormone therapy to prevent disease and prolong life in postmenopausal women
21. Postmenopausal hormone replacement therapy and cardiovascular risk reduction
22. Estrogen and the blood vessel wall
23. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
24. The clinical aspects of estrogen and the cardiovascular system
25. Sex differences in coronary heart disease: Why are women so superior? The 1995 Ancel Keys Lecture
26. Postmenopausal hormone therapy and mortality
27. The protective effects of estrogen on the cardiovascular system
28. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
29. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
30. Lp(a) lipoprotein. Relationship to cardiovascular disease risk factors, exercice, and estrogen
31. Clinical pharmacology of estrogens: Cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women
32. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women
33. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
34. Oestrogenes et atherosclerose: Donnees recentes et perspectives
35. Effect of 17β-oestradiol on endothelin-1 release by human umbilical vein endothelial cells
36. In vitro and in vivo effects of estrogens on prostacyclin and thromboxane and on other vasoactive compounds
37. Urinary cGMP-excretion during transdermal hormone replacement therapy in postmenopausal women
38. Plasma soluble adhesion molecule in patients with coronary artery disease
39. Estrogen decreases the level of circulating cellular adhesion molecules in coronary artery disease
40. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
41. 17β-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat
42. Estrogen and a novel tissue selective estrogen receptor modulator raloxifene directly modulate vascular smooth muscle cell functions: Implications in the cardioprotective mechanism of estrogen
43. 17β-oestradiol inhibits growth of human vascular smooth muscle: Similar effects in cells from females and males
44. Estrogen and progesterone inhibit vascular smooth muscle proliferation
45. Sterodes ovariens et systeme vasculaire: Role dans la proliferation vasculaire et implication en pathologie veineuse
46. The pharmacological profile of TX066 (17α-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative
47. Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women
48. Etude comparative des effets de l'acetate de nomegestrol (NOM) et de l'acetate de norethisterone (NOR) sur les lipides au cours du traitement substitutif de la menopause
49. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries
50. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys
51. Reactivity based coronary vasospasm independent of atherosclerosis in Rhesus monkeys
52. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
53. Ovarian steroid protection against coronary artery hyperactivity in Rhesus monkeys
54. Coadministration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses
55. Progesterone has calcium antagonistic properties in the rabbit coronary artery
56. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro
57. Progestins and vascular function
58. Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins
59. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery
60. Effects of a pure antiestrogen and progesterone on estrogen-mediated alterations of blood flow and progesterone receptor expression in the aorta of ovariectomized rabbits
61. Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate
62. Does the progestin norethisterone acetate influence the effect of estradiol on the production of vasoactive substances in postmenopausal women?
63. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
64. The effects of continuous combined oral oestradiol and norethisterone on pulsatility index in internal carotid artery in previously untreated women
65. Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women
66. Gestagen replacement does not abolish the beneficial effect of estrogen replacement on endothelial dysfunction in postmenopausal women
67. A preliminary study on the effect of hormone replacement therapy on peripheral flow velocity in postmenopausal women
68. Hormone replacement therapy enhances endothelium-dependent flow-mediated vasodilatation in postmenopausal women with angiographically proven coronary atherosclerosis
69. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
70. Natural progesterone administered vaginally does not reverse the beneficial effects of E2 on exercice induced myocardial ischemia and may have a beneficial action of its own
71. Independent effects of 17β-oestradiol and dydrogesterone on ACE activity in postmenopausal women
72. Is there a dose-dependent effect of the progestin dienogest (DNG), continuously combined with estradiol valerate, on blood pressure in postmenopausal women?
73. Estrogen/progestine replacement therapy improves the course of coronary artery disease in menopausal women
74. Carotid artery wall thickness in women treated with hormone replacement therapy
75. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women
76. Longterm effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease
77. Hormone replacement therapy (HRT) attenuates endothelial activation/damage in postmenopausal females
78. Hormone replacement therapy among postmenopausal women with acute myocardial infarction: Insights from GUSTO-III
79. Effects of hormone replacement therapy on serum monocyte chemoattractant protein-1 in postmenopausal women
80. Hormone replacement therapy increases arterial compliance in postmenopausal women
81. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane
82. 17β-estradiol but not medroxyprogesterone inhibits neointima formation after balloon injury of rat carotid arteries
83. Effect of oestrogen therapy and progesterone on the blood flow in the lower urinary tract of the rabbit
84. The effect of progesterone on estrogen-induced uterine blood flow
85. Uterine blood flow and its distribution after chronic estrogen and progesterone administration
86. Effect of progestin administration on peripheral vascular responsiveness in postmenopausal women
87. Effects of estrogen and progestin on aortic size and compliance in postmenopausal women
88. Age-related deterioration in arterial structure and function in postmenopausal women: Impact of hormone replacement therapy
89. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women
90. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
91. Comparative effect of continuous combined hormone replacement therapy with either conjugated equine oestrogens plus medroxyprogesterone acetate or 17β-oestradiol plus norethisterone acetate on brachial artery blood flow
92. L'administration cyclique de nomegestrol acetate n'altere pas les effets vasodilatateurs de l'estradiol sur l'artere uterine